Task: Answer the multiple-choice question.
Query: Which drug exhibits a -0.803% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: CC(c1nnc(SCC(=O)Nc2ccc3[nH]c(=O)[nH]c3c2)n1Cc1ccccc1)N(C)C
b: Cc1cccc(OCC(=O)Nc2ccncc2)c1
Answer: b. Cc1cccc(OCC(=O)Nc2ccncc2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cccc(OCC(=O)Nc2ccncc2)c1
Cc1cccc(OCC(=O)Nc2ccncc2)c1
2-(3-methylphenoxy)-N-pyridin-4-ylacetamide